Volume 109, Issue 3, Pages 429–436
Authors:
Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology
Abstract:
The value of preimplantation genetic testing for aneuploidy (PGT-A) as a screening test for in vitro fertilization (IVF) patients has yet to be determined. Several studies demonstrate higher birth rates after aneuploidy testing and elective single-embryo transfer (eSET), suggesting the potential for this testing to decrease the risk of multiple gestations, though these studies have important limitations.
Comments
Has the ASRM issued any updated statements following the 2018 Committee Opinion on PGT-A?